Biopsy Incisional With Trepan in Periocular Lesions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-12-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to identify accuracy rates of 2mm punch biopsy technique in diagnosing periocular malignancy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety of Lung Cryobiopsy in People With Cancer

NCT04548830

Lung Cancer

ACTIVE_NOT_RECRUITING PHASE2

Detection of Circulating Tumor Cells in Patients With Sarcomas

NCT02983539

Leiomyosarcoma Pleomorphic Liposarcoma Synovial Sarcoma +1 more

UNKNOWN

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

NCT00540566

Malignant Melanoma Merkel Cell Carcinoma Basal Cell Carcinoma +12 more

COMPLETED

New Biopsy Technique for Uveal Melanoma

NCT01924923

Uveal Melanoma

COMPLETED

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

NCT00952939

Intraocular Melanoma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In each case, the histology obtained at biopsy was compared with that identified at the time of tumor excision.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Punch Biopsy

Group Type EXPERIMENTAL

Punch Biopsy

Intervention Type PROCEDURE

1. Instillation of anesthetic eye drops.
2. Asepsis
3. Placement of surgical cloths and drapes
4. Infiltration of the involved region with anesthetic solution plus adrenalin in1:200.00 dilution.
5. Trephination of the most typical area of the lesion with a punch (2mm in diameter) of stainless steel by applying gentle pressure and twisting the trephine until its introduction into the suspicious lesions
6. Removal of the excised tissue with the aid of an insulin needle or conjuntival forceps, the base then bein cut with an number 11 surgical blade

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Punch Biopsy

1. Instillation of anesthetic eye drops.
2. Asepsis
3. Placement of surgical cloths and drapes
4. Infiltration of the involved region with anesthetic solution plus adrenalin in1:200.00 dilution.
5. Trephination of the most typical area of the lesion with a punch (2mm in diameter) of stainless steel by applying gentle pressure and twisting the trephine until its introduction into the suspicious lesions
6. Removal of the excised tissue with the aid of an insulin needle or conjuntival forceps, the base then bein cut with an number 11 surgical blade

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Punch 2 mm Biopsy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All lesions were initially examined at the slitlamp, after which lesions with malignant characteristics such as texture, size or color alterations asociated with ulceration, prominent borders or elevated contours, irregular borders, telangiectasias or loss of eyelashes were included.